Skip to main content
Log in

Curdlan gels as protein drug delivery vehicles

  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

The use of curdlan, a natural β-1,3-glucan, in protein drug delivery vehicles was studied by carrying out in vitro release studies with curdlan gels containing bovine serum albumin (BSA) as a model protein. Addition of urea (8 M) decreased the gel formation temperature to 37 °C. Curdlan was hydroxyethylated in order to form gels under mild conditions such as physiological temperature and pH. In gels formed in 8 M urea solution, urea was almost released after 2 h while BSA was completely released after 45–100 h. The total time for complete release of BSA increased with curdlan concentration within gels. The strength of hydroxyethylated curdlan gels (385.7 dyne cm−2) was weaker than that of curdlan gels formed in 8 M urea solution (6277 dyne cm−2).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Gombots W, Pettit DK (1995) Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem. 6: 332–351.

    Google Scholar 

  • Harada T (1977) Production, properties, and application of curdlan. In: Sanford PA, Laskin A, eds. Extracellular Microbial Polysaccharides. Washington DC: American Chemical Society, pp. 265–283.

    Google Scholar 

  • Harada T, Misaka A, Saito H (1968) Curdlan: a bacterial gelforming _-1,3-glucan. Arch. Biochem. Biophys. 124: 292–298.

    PubMed  Google Scholar 

  • Jezequel V (1998) Curdlan: a new functional _-glucan. Cereal Foods World 43: 361–364.

    Google Scholar 

  • Kanke M, Koda K, Koda Y, Katayama H (1992) Application of curdlan to controlled drug delivery. I. The preparation and evaluation of theophylline-containing curdlan tablets. Pharm. Res. 9: 414–418.

    PubMed  Google Scholar 

  • Kanke M, Katayama H, Nakamura M (1995a) Application of curdlan to controlled drug delivery. II. In vitro and in vivo drug release studies of theophylline-containing curdlan tablets. Biol. Pharm. Bull. 18: 1104–1108.

    PubMed  Google Scholar 

  • Kanke M, Tanabe E, Katayama H, Koda Y, Yoshitomi H (1995b) Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro. Biol. Pharm. Bull. 18: 1154–1158.

    PubMed  Google Scholar 

  • Langer R (1998) Drug delivery and targeting.Nature 392 (6679 Suppl): 5–10.

    PubMed  Google Scholar 

  • Renn DW (1997) Purified curdlan and its hydroxyalkyl derivatives: preparation, properties and applications. Carbohydr. Polym. 33: 219–225.

    Google Scholar 

  • Watanabe K, Yakou S, Takayama K, Machida T, Nagai T (1992) Factors affecting prednisolone release from hydrogels prepared with water-soluble dietary fibers, xanthan and locust bean gums. Chem. Pharm. Bull. 40: 459–462.

    PubMed  Google Scholar 

  • West JL, Hubbell JA (1995) Photopolymerized hydrogel materials for drug delivery applications. Reactive Polym. 25: 139–147.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, B.S., Jung, I.D., Kim, J.S. et al. Curdlan gels as protein drug delivery vehicles. Biotechnology Letters 22, 1127–1130 (2000). https://doi.org/10.1023/A:1005636205036

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005636205036

Navigation